This monograph presents guidelines for the use of antiretroviral drugs (ARVs) in pregnant women and for preventing perinatal transmission of HIV to their infants and summarizes programmatic considerations and scientific rationale behind the guidelines. The monograph includes recommendations for ARV treatment for pregnant women and women of childbearing age.
This report provides information on the World Health Organization’s (WHO) Adherence to Long-term Therapies Project to improve the rates of adherence to therapies used in treating chronic conditions. The report begins by defining the term adherence and the problem of poor adherence, showing how poor adherence affects policy makers and health managers. It presents guidance for countries for improving adherence rates using information derived from lessons learned from reviews and presents the disease-specific reviews. The report also discusses nine chronic conditions that were reviewed.
This report presents guidelines for treating opportunistic infections (OIs) in children infected with HIV and children who have been exposed to HIV. It is noted that OIs in children reflect primary infection, whereas in adults OIs are secondary to reactivation of previously-acquired opportunistic pathogens before HIV infection when their immunity was intact. In addition, among children with perinatal HIV, the opportunistic pathogen is occurring after HIV infection is established and the immune system may already be compromised.
This manual discusses the diagnosis and treatment of TB and HIV coinfection. It gives background information on TB and HIV, presents a framework for effective TB control, discusses the diagnosis of pulmonary and extrapulmonary TB in adults and children, and of HIV in adults and children with TB.
This information sheet discusses why treatment for hepatitis C virus infection is challenging for persons recovering from drug and alcohol abuse. It describes some of the side effects of treatment and suggests ways to manage them, reports comments about treatment by others in recovery, and other ways of dealing with side effects. The information sheet advises how to deal with memories and feelings of injecting drug use that can be brought about by the act of injecting interferon and where to get more information.
This information sheet discusses treatment for hepatitis C virus infection. It explains the three treatments approved by the Food and Drug Administration for this disease, the length of treatment, how treatment helps the patient, the different responses to treatment, what makes treatment more likely to work, whether a liver biopsy is necessary before starting treatment, when would be a good time to start, what should one do before starting treatment, and who to contact for more information.
This information sheet discusses what to expect while being treated for hepatitis C virus infection. It explains what a patient needs to know about treatment including side effects, treatment time, laboratory tests the doctor may order during treatment, whether it would be possible to work during treatment, taking other medicines to control side effects, the need for a liver biopsy during treatment, and where to get more information.
This information sheet discusses finishing treatment for hepatitis C virus infection. It provides suggestions on what a patient should do after completing treatment, including making a decision about taking a break if the treatment did not clear the virus from one’s blood or trying new drugs right away, talking to the doctor before trying herbs, getting liver function tests every six months or every year, and getting regular checkups.
This information sheet discusses liver cancer. It explains what hepatocellular carcinoma (HCC) is, its symptoms, and what the treatment for HCC entails. It also provides information about how to prevent HCC and protect oneself from hepatitis B and hepatitis C.
This information sheet discusses treatment for hepatitis C virus infection. It explains what the treatments are, what the treatments try to do, how the medicines are given, side effects of treatments and ways to lessen the side effects, how the doctor knows if the treatments are working, risks to the partner of a person being treated for hepatitis C, and where to get more information.